Cargando…
Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy
Tumor necrosis factor (TNF) ligand related molecule 1A (TL1A), also termed TNF superfamily member 15 and vascular endothelial growth inhibitor is important for tumorigenicity and autoimmunity. However, the function of TL1A in diabetic retinopathy (DR) remains to be elucidated. The present study esta...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364842/ https://www.ncbi.nlm.nih.gov/pubmed/28000874 http://dx.doi.org/10.3892/mmr.2016.6048 |
_version_ | 1782517404266397696 |
---|---|
author | Zhang, Zhu-Hong Chen, Qing-Zhong Jiang, Feng Townsend, Todd A. Mao, Chun-Jie You, Cai-Yun Yang, Wen-Hui Sun, Zhi-Yong Yu, Jin-Guo Yan, Hua |
author_facet | Zhang, Zhu-Hong Chen, Qing-Zhong Jiang, Feng Townsend, Todd A. Mao, Chun-Jie You, Cai-Yun Yang, Wen-Hui Sun, Zhi-Yong Yu, Jin-Guo Yan, Hua |
author_sort | Zhang, Zhu-Hong |
collection | PubMed |
description | Tumor necrosis factor (TNF) ligand related molecule 1A (TL1A), also termed TNF superfamily member 15 and vascular endothelial growth inhibitor is important for tumorigenicity and autoimmunity. However, the function of TL1A in diabetic retinopathy (DR) remains to be elucidated. The present study established a diabetes mellitus (DM) rat model to investigate TL1A, vascular endothelial growth factor (VEGF), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) expression levels in the retina, vitreous and serum of rats with DM at different stages (1 month group, 3 month group and 6 month group). The present study determined that TL1A expression levels in the retina and vitreous from the DM 1 month group were significantly lower compared with the control group. However, TL1A levels in the retina and vitreous were significantly increased in advanced stages of DM compared with the control group. Furthermore, the levels of VEGF in the retina and vitreous were significantly higher in the DM groups compared with the control group. The expression levels of TNF-α and IL-1β in the retina and vitreous were significantly higher in DM 3 month and 6 month groups compared with the control group. It is of note that the expression levels of TL1A were significantly lower in the DM 1 and 3 month groups compared with the control group; however, they were significantly increased in the DM 6 month group compared with the DM 3 month group. The expression levels of VEGF, TNF-α and IL-1β in blood serum have been observed to exhibit similar expression change dynamics as those of the retina and vitreous. Therefore, these findings suggest that TL1A may be a protective factor of DR, and may provide a rationale for the development of novel therapeutic strategies to treat DR. |
format | Online Article Text |
id | pubmed-5364842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-53648422017-05-15 Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy Zhang, Zhu-Hong Chen, Qing-Zhong Jiang, Feng Townsend, Todd A. Mao, Chun-Jie You, Cai-Yun Yang, Wen-Hui Sun, Zhi-Yong Yu, Jin-Guo Yan, Hua Mol Med Rep Articles Tumor necrosis factor (TNF) ligand related molecule 1A (TL1A), also termed TNF superfamily member 15 and vascular endothelial growth inhibitor is important for tumorigenicity and autoimmunity. However, the function of TL1A in diabetic retinopathy (DR) remains to be elucidated. The present study established a diabetes mellitus (DM) rat model to investigate TL1A, vascular endothelial growth factor (VEGF), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) expression levels in the retina, vitreous and serum of rats with DM at different stages (1 month group, 3 month group and 6 month group). The present study determined that TL1A expression levels in the retina and vitreous from the DM 1 month group were significantly lower compared with the control group. However, TL1A levels in the retina and vitreous were significantly increased in advanced stages of DM compared with the control group. Furthermore, the levels of VEGF in the retina and vitreous were significantly higher in the DM groups compared with the control group. The expression levels of TNF-α and IL-1β in the retina and vitreous were significantly higher in DM 3 month and 6 month groups compared with the control group. It is of note that the expression levels of TL1A were significantly lower in the DM 1 and 3 month groups compared with the control group; however, they were significantly increased in the DM 6 month group compared with the DM 3 month group. The expression levels of VEGF, TNF-α and IL-1β in blood serum have been observed to exhibit similar expression change dynamics as those of the retina and vitreous. Therefore, these findings suggest that TL1A may be a protective factor of DR, and may provide a rationale for the development of novel therapeutic strategies to treat DR. D.A. Spandidos 2017-02 2016-12-14 /pmc/articles/PMC5364842/ /pubmed/28000874 http://dx.doi.org/10.3892/mmr.2016.6048 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Zhang, Zhu-Hong Chen, Qing-Zhong Jiang, Feng Townsend, Todd A. Mao, Chun-Jie You, Cai-Yun Yang, Wen-Hui Sun, Zhi-Yong Yu, Jin-Guo Yan, Hua Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
title | Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
title_full | Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
title_fullStr | Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
title_full_unstemmed | Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
title_short | Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy |
title_sort | changes in tl1a levels and associated cytokines during pathogenesis of diabetic retinopathy |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364842/ https://www.ncbi.nlm.nih.gov/pubmed/28000874 http://dx.doi.org/10.3892/mmr.2016.6048 |
work_keys_str_mv | AT zhangzhuhong changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT chenqingzhong changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT jiangfeng changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT townsendtodda changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT maochunjie changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT youcaiyun changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT yangwenhui changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT sunzhiyong changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT yujinguo changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy AT yanhua changesintl1alevelsandassociatedcytokinesduringpathogenesisofdiabeticretinopathy |